Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 07-Oct-24 8:55 PM View:  | Scholar Rock Holding Corp (SRRK) | 07-Oct-24 | Private Sale (Planned) | 1,175,710 | $29.25 | $34,385,700.00 | (9%) 13.08M to 11.9M | |
| 18-Sep-24 5:00 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 16-Sep-24 | Option Exercise | 2,667 | -- | -- | 40% 6.67K to 9.33K | |
| 01-Jul-24 4:40 PM View: | Alumis Inc. (ALMS) | 01-Jul-24 | Grant | 1,704,000 | -- | -- | 100% 0 to 1.7M | |
| 01-Jul-24 4:40 PM View: | Alumis Inc. (ALMS) | 01-Jul-24 | Conversion | 1,704,000 | -- | -- | 100% 1.7M to 3.41M | |
| 01-Jul-24 4:40 PM View: | Alumis Inc. (ALMS) | 01-Jul-24 | Disposition | 1,704,000 | -- | -- | (50%) 3.41M to 1.7M | |
| 04-Jun-24 4:41 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 01-Jun-24 | Option Exercise | 4,000 | -- | -- | 150% 2.67K to 6.67K | |
| 29-Feb-24 7:33 PM View: | vTv Therapeutics Inc. (VTVT) | 27-Feb-24 | Grant | 224,732 | $11.81 | $2,654,080.00 | 550% 40.89K to 265.62K | |
| 14-Feb-24 9:07 PM View: | Mineralys Therapeutics, Inc. (MLYS) | 12-Feb-24 | Grant | 555,555 | $13.50 | $7,499,990.00 | 12% 4.52M to 5.07M | 5% |
| 26-Dec-23 5:24 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 21-Dec-23 | Purchase | 904,977 | $4.42 | $4,000,000.00 | 102% 884.11K to 1.79M | |
| 13-Nov-23 2:51 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition | 8,111 | $19.00 | $154,109.00 | (1%) 686.69K to 678.58K | |
| 13-Nov-23 2:51 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 37,887 | $19.00 | $719,853.00 | (6%) 678.58K to 640.69K | |
| 13-Nov-23 2:51 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 640,688 | $19.00 | $12,173,100.00 | (100%) 640.69K to 0 | |
| 18-Oct-23 5:46 PM View: | Scholar Rock Holding Corp (SRRK) | 16-Oct-23 | Private Purchase Duplicate | 2,189,780 | $6.85 | $15,000,000.00 | 48% 4.6M to 6.79M | |
| 19-Sep-23 4:46 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 16-Sep-23 | Option Exercise | 2,666 | -- | -- | 100% 0 to 2.67K | |
| 11-Aug-23 4:04 PM View: | Chinook Therapeutics, Inc. (KDNY) | 11-Aug-23 | Disposition | 3,300 | -- | -- | (< 1%) 5.17M to 5.16M | |
| 11-Aug-23 4:04 PM View: | Chinook Therapeutics, Inc. (KDNY) | 11-Aug-23 | Disposition | 5,161,890 | -- | -- | (100%) 5.16M to 0 | |
| 31-May-23 7:25 PM View: | Chinook Therapeutics, Inc. (KDNY) | 26-May-23 | Option Exercise | 3,300 | -- | -- | 100% 0 to 3.3K | |
| 25-May-23 8:37 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 24-May-23 | Grant | 8,111 | -- | -- | 1% 678.58K to 686.69K | |
| 16-Feb-23 4:54 PM View: | Mineralys Therapeutics, Inc. (MLYS) | 14-Feb-23 | Conversion | 3,581,860 | -- | -- | 100% 0 to 3.58M | |
| 16-Feb-23 4:54 PM View: | Mineralys Therapeutics, Inc. (MLYS) | 14-Feb-23 | Private Purchase | 937,500 | $16.00 | $15,000,000.00 | 26% 3.58M to 4.52M | |
| 01-Jun-22 4:13 PM View: | Chinook Therapeutics, Inc. (KDNY) | 27-May-22 | Market Purchase | 570,000 | $14.00 | $7,980,000.00 | 12% 4.59M to 5.16M | < 1% |
| 27-May-22 4:18 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 25-May-22 | Grant | 7,737 | -- | -- | 1% 670.84K to 678.58K | |
| 17-Nov-21 12:05 PM View: | Chinook Therapeutics, Inc. (KDNY) | 15-Nov-21 | Private Purchase | 1,215,000 | $14.00 | $17,010,000.00 | 36% 3.38M to 4.59M | |
| 20-Aug-21 5:37 PM View: | Chinook Therapeutics, Inc. (KDNY) | 18-Aug-21 | Market Purchase | 208,500 | $11.98 | $2,497,830.00 | 7% 3.17M to 3.38M | 1% |
| 01-Jun-21 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-May-21 | Grant | 7,029 | -- | -- | 1% 663.81K to 670.84K | |
| 12-Mar-21 7:51 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 12-Mar-21 | Market Purchase | 147,000 | $21.29 | $3,129,630.00 | 28% 516.81K to 663.81K | (2%) |
| 12-Mar-21 7:51 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 10-Mar-21 | Market Purchase | 90,000 | $20.96 | $1,886,620.00 | 21% 426.81K to 516.81K | (< 1%) |
| 11-Dec-20 8:12 PM View: | Jiya Acquisition Corp. (JYAC) | 09-Dec-20 | Grant | 7,041 | $10.00 | $70,410.00 | 1% 500.0K to 507.04K | |
| 11-Dec-20 8:52 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 08-Dec-20 | Grant | 625,000 | -- | -- | 49% 1.27M to 1.9M | |
| 25-Nov-20 3:10 PM View: | Jiya Acquisition Corp. (JYAC) | 23-Nov-20 | Grant | 500,000 | $10.00 | $5,000,000.00 | 100% 0 to 500.0K | |
| 07-Oct-20 9:08 PM View: | Chinook Therapeutics, Inc. (KDNY) | 05-Oct-20 | Grant | 3,168,390 | -- | -- | 100% 0 to 3.17M | |
| 19-Aug-20 4:03 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 18-Aug-20 | Market Sale (Planned) | 158,583 | $13.10 | $2,076,720.00 | (11%) 1.43M to 1.27M | 11% |
| 19-Aug-20 4:03 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 17-Aug-20 | Market Sale (Planned) | 744 | $13.00 | $9,672.00 | (< 1%) 1.43M to 1.43M | 10% |
| 06-Jul-20 4:00 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 01-Jul-20 | Market Sale (Planned) | 4,627 | $11.01 | $50,965.90 | (< 1%) 1.44M to 1.43M | (6%) |
| 25-Jun-20 8:38 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 25-Jun-20 | Market Sale (Planned) | 54,972 | $11.15 | $612,850.00 | (4%) 1.49M to 1.44M | (5%) |
| 25-Jun-20 8:38 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 24-Jun-20 | Market Sale (Planned) | 48,775 | $11.07 | $539,788.00 | (3%) 1.54M to 1.49M | (6%) |
| 25-Jun-20 8:38 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 23-Jun-20 | Market Sale (Planned) | 50,953 | $11.11 | $565,930.00 | (3%) 1.59M to 1.54M | (5%) |
| 01-Jun-20 7:07 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 28-May-20 | Grant | 1,595 | -- | -- | < 1% 425.21K to 426.81K | |
| 19-May-20 7:10 PM View: | Seattle Genetics Inc. (SGEN) | 15-May-20 | Grant | 1,335 | -- | -- | 3% 40.17K to 41.5K | |
| 07-May-20 7:58 PM View: | Seattle Genetics Inc. (SGEN) | 05-May-20 | Option Exercise | 8,500 | $20.06 | $170,510.00 | 21% 40.17K to 48.67K | |
| 07-May-20 7:58 PM View: | Seattle Genetics Inc. (SGEN) | 05-May-20 | Market Option Sale | 8,500 | $167.26 | $1,421,710.00 | (17%) 48.67K to 40.17K | |
| 02-Dec-19 4:05 PM View: | Aravive, Inc. (ARAV) | 02-Dec-19 | Private Purchase | 133,333 | $7.50 | $999,998.00 | 28% 474.55K to 607.88K | |
| 22-Nov-19 6:35 PM View: | Seattle Genetics Inc. (SGEN) | 21-Nov-19 | Option Exercise | 17,500 | $19.02 | $332,850.00 | 44% 40.17K to 57.67K | |
| 22-Nov-19 6:35 PM View: | Seattle Genetics Inc. (SGEN) | 21-Nov-19 | Market Option Sale | 17,500 | $119.78 | $2,096,120.00 | (30%) 57.67K to 40.17K | |
| 30-Aug-19 2:32 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 28-Aug-19 | Market Purchase | 5,207 | $60.32 | $314,086.00 | 1% 420.01K to 425.21K | (56%) |
| 22-Aug-19 7:53 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 22-Aug-19 | Grant | 1,180 | $64.30 | $75,874.00 | < 1% 418.83K to 420.01K | (58%) |
| 22-Aug-19 7:53 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 21-Aug-19 | Grant | 29,000 | $67.12 | $1,946,480.00 | 7% 389.83K to 418.83K | (60%) |
| 22-Aug-19 7:53 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 20-Aug-19 | Grant | 37,604 | $65.85 | $2,476,220.00 | 11% 352.22K to 389.83K | (59%) |
| 21-Jun-19 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 20-Jun-19 | Grant | 1,570 | -- | -- | < 1% 350.65K to 352.22K | |
| 22-May-19 9:34 PM View: | Seattle Genetics Inc. (SGEN) | 20-May-19 | Grant | 2,963 | -- | -- | 8% 37.2K to 40.17K |